< Back to previous page

Publication

Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era (Jan, 10.1007/s12325-021-01990-6, 2022)

Journal Contribution - Journal Article

Journal: Advances in Therapy

ISSN: 0741-238X

Issue: 5

Volume: 39

Pages: 2281 - 2281

Publication year:2022

WoS Id: 000768674600002
PubMed Id: 35287234
DOI: https://doi.org/10.1007/s12325-022-02082-9
Institutional Repository URL: https://lirias.kuleuven.be/3710547

Accessibility:Open